Leukotriene B4 [LTB4, (5S,12R)-hydroxyeicosa-6,14-cis-8,10-trans-tetraenoic acid], a potent mediator of inflammation, is released from neutrophils by agonists that provoke degranulation of the cell. To examine whether degranulation is a necessary requirement for synthesis and metabolism of LTB4 (or of other arachidonate metabolites), we prepared neutrophil-derived cytoplasts (neutroplasts), organelle-depleted vesicles of cytoplasm surrounded by the plasma membrane. In the presence of extracellular Ca2+ with or without exogenous arachidonic acid (150,M), neutroplasts were exposed to the Ca2+ ionophore A23187 (10 /M) and the resultant lipoxygenation products of arachidonate were determined. Neutrophils metabolize arachidonic acid to 5-HETE > 15-HETE > LTB4 > all-trans-LTB4 isomers. Neutroplast products of arachidonate lipoxygenation were 15-HETE > 5-HETE > LTB4 > all-trans-LTB4 isomers. Neutroplasts, like neutrophils, were capable of converting LTB4 into its 20-hydroxy and 20-carboxy metabolites. Finally, neutroplasts could utilize intrinsic arachidonate, since the neutroplasts synthesized LTB4 (30 pmol/mg of protein) in the absence of added arachidonic acid. The data demonstrate that neutrophil degranulation is not required for synthesis or metabolism of LTB4 by neutrophils.
INTRODUCTION
In response to soluble or particulate stimuli, neutrophils aggregate, move toward a chemoattractant, release toxic oxygen species and produce inflammatory mediators from arachidonate (i.e. LTB4) (Weissman et al., 1981) .
It is unclear, however, whether any or all of these processes is linked to degranulation (which is provoked by the same set of stimuli) either as a necessary prerequisite or as a parallel event (Ward & Becker, 1970; Mehta et al., 1981; Boxer et al., 1982; Fletcher et al., 1982) . By using neutrophil-derived cytoplasts or neutroplasts, Roos et al. (1983) and Korchak et al. (1983) have shown that these organelle-depleted cell fragments are capable of aggregating, generating 02-and ingesting particles, despite their lack of granules.
LTB4 is one of the most potent endogenous mediators of inflammation that have been described (Weissmann et al., 1981; Samuelsson, 1983; Lewis & Austen, 1984) . In neutrophils it serves both as a potent chemotactic agent and a complete secretagogue. LTB4 is synthesized by neutrophils, as well as by other phagocytic cells, after their stimulation with Ca2+ ionophores or after uptake of particles such as opsonized zymosan (Borgeat & Samuelsson, 1979a; Rouzer et al., 1980; Claesson et al., 1981) . Whether the synthesis and metabolism of LTB4 is linked to the degranulation that accompanies exposure of cells to ionophores or particles has not been examined. To determine whether a stimulus provoking degranulation is required for the generation of LTB4, we have compared neutroplasts with intact neutrophils and found that, when neutroplasts were exposed to the Ca2+ ionophore A23187 in the presence of external Ca 2+ they are as capable as intact cells of synthesizing and catabolizing LTB4; stimulus-induced degranulation is therefore unnecessary.
MATERIALS AND METHODS Buffers and reagents
Hepes buffer comprised 150 mM-Na+, 5 mm-K+, 1.2 mM-Mg2+, 1.3 mM-Ca2+, 155 mM-Cl, 10 mM-Hepes and 5 mM-glucose, pH 7.45. Phosphate-buffered saline contained 10 mM-P043-, 5 mM-glucose and 138 mM-NaCl, pH 7.42; ACD contained 67 mM-citric acid, 85 mMsodium citrate and 110 mM-dextrose. Cytochalasin B was from Aldrich, Ficoll 70 was from Sigma, arachidonic acid was from Nu Chek and ionophore A23187 was from Calbiochem. Methanol, hexane and propan-2-ol were h.p.l.c. grade from Burdick and Jackson, and anhydrous diethyl ether (h.p.l.c. grade) was from J. T. Baker. Standard LTB4, all-trans-LTB4 isomers and monoHETEs were kindly given by Dr [(5S,12R)-hydroxyeicosa-6,14-cis-8,10-trans-tetraenoic acid] ; (5S,12S)-di-HETE, (5S,12S)-dihydroxyeicosa-6-trans, 14-cis-8-cis, 10-trans-tetraenoic acid; HETE, hydroxyeicosatetraenoic acid; all-trans-LTB4, (5S,12R)-and (5S,12S)-hydroxyeicosa-6,8,10-trans-14-cis-tetraenoic acids; ACD, acid/citrate/dextrose; s.p.-or r.p.-h.p.l.c., straight-or reverse-phase h.p.l.c.; PGB2, prostaglandin B2. t To whom correspondence and reprint requests should be addressed.
volunteers; aliquots (6 ml) were collected in ACD (1 ml) and were spun at 200 g in a Neutroplast preparation Neutroplasts were prepared by the method of Roos et al. (1983) . Briefly, 1 x 108 neutrophils were mixed with 12.5% (w/v) Ficoll 70 containing 5, g of cytochalasin B/ml and layered over a discontinuous gradient of 16% and 25% Ficoll 70 containing 5 jug of cytochalasin B/ml that had been prewarmed to 37 'C. A portion of intact neutrophils was removed beforehand to serve as a positive control. The cells were spun at 82000 g in a Beckman L-2 ultracentrifuge (SW27 rotor; 35 'C; 30 min). The layer that formed at the 12.5% /16% -Ficoll interface was removed, washed three times in Hepes buffer and resuspended to a concentration of 9 x 107 neutroplasts/ml, assuming one neutroplast is formed per neutrophil, as had previously been shown (Korchak et al., 1983) . A portion was removed for determination of protein concentration, which was done by the method of Lowry et al. (1951) , with lysozyme as the standard.
Neutroplasts and neutrophils were incubated for 15 min at 37 'C with or without 150 /tM-arachidonic acid in 0.1 % ethanol and then stimulated with 10 ,tM-A23187 for 5 min. The reaction was stopped by the addition of 2 vol. of methanol and kept at -20 'C overnight. Extraction and separation procedures Lipoxygenase products were isolated by diethyl ether extraction by the method of Borgeat & Samuelsson (1979a, b) . Briefly, the cell mixture was spun at 1600 g at 4 'C in a Sorvall RC3 centrifuge, the supernatant was decanted, and the pH adjusted to 3.0. The supernatant was then extracted with diethyl ether by using diethyl ether, water and supernatant in the proportions 2: 1: 1 (by vol.). The resulting water phase was discarded, and the diethyl ether phase was washed twice more with water. The ether phase was evaporated to dryness under a stream ofN2 and the products were separated on an Altex Ultrasphere ODS (5,m particle size; 4.6 mm x 25 cm) r.p.-h.p.l.c. column (Beckman Instruments), a methanol/water/acetic acid (7500:2500: 1, by vol.) solvent system being used. The eluate was monitored at 270 nm for di-HETEs and 235 nm for mono-HETEs. Fractions were collected, dried under a stream of N2 and resuspended in methanol until further use. Concentrations ofproducts were determined bymeasuringu.v. absorbance at 270 nm for di-HETEs (absorption coefficient 45000 litre mol-h cm-') and at 235 nm for mono-HETEs (absorption coefficient 30500 litre-mol-1 cm-'). The average recovery of arachidonic acid metabolites as determined by comparing the area under the peak of the r.p.-h.p.l.c. elution profile of 100 ng of PGB2 with that of the same quantity of PGB2 that had been added in six experiments, was 105+30%. Samples for s.p.-h.p.l.c. were resuspended in 100,ul of acid methanol and 800,1 of ethereal diazomethane was added. Samples were vortex-mixed and incubated for 15 min at room temperature. They were evaporated to dryness under N2 and the esterification procedure was repeated. Samples were resuspended in the appropriate h.p.l.c. buffer and run on an Altex Si column (4.6 mm x 25 cm). Di-HETEs were separated by using a solvent system comprising hexane/propan-2-ol/acetic acid (9500:500:1, by vol.) and monitored at 270 nm. w-Oxidized compounds were separated by using a hexane/propan-2-ol/acetic acid (9000:1000: 1, by vol.) solvent system and monitored at 270 nm. These compounds possessed the triplet absorption maxima of a conjugated triene and were identified by comparison of elution times with published standards.
The ratios of the compounds were determined and were used to calculate the molar quantities obtained by the r.p. procedure.
Neutrophil aggregation
Aggregation was measured as previously described (Craddock et al., 1977) . Briefly, 1.25 x 106 cells were stirred in a 100 1l silicone-treated cuvette in Hepes buffer containing 5,ug of cytochalasin B/ml. They were stimulated with various concentrations of LTB4 derived from either neutrophils or neutroplasts. Aggregation was measured as an increase in light transmission with respect to time.
RESULTS

Synthesis of LTB4 by neutrophils and neutroplasts
In order to test the hypothesis that intact neutrophils containing granules are required for LTB4 generation, we prepared neutrophil-derived cytoplasts or neutroplasts by the method of Roos et al. (1983) . Neutrophils and neutroplasts were incubated with or without A23187 (10 #M) for 5 min after preincubation with arachidonic acid (150 /UM) in 0.1 % ethanol. Neither unstimulated neutrophils nor neutroplasts made di-HETE products, but both generated mono-HETEs in the presence of added arachidonate (see Table 1 ). Neutrophils and neutroplasts pretreated with arachidonate and stimulated with A23187 generated both mono-and di-HETES (Table 1; Fig. 1 ). Fig. l(a) separation. Neutrophil preparations contained 7 0 ofthis product (Table 1) .
To confirm that neutroplast-generated LTB4 possessed biological activity, we tested it for its ability to elicit neutrophil aggregation. Although it was not possible to perform a complete dose-response analysis, owing to the small quantities of LTB4 produced by each preparation of neutroplasts, equal concentrations of neutrophil and Vol. 233 neutroplast LTB4 consistently produced the same degree of neutrophil aggregation (Fig. 2) . All-trans-LTB4, here derived from neutroplasts, caused no neutrophil aggregation at the highest concentration used (Fig. 2) . Metabolism of LTB4 by neutrophils and neutroplasts During cell activation, LTB4 is converted into its more polar metabolites, the 20-hydroxy and 20-carboxy compounds, which possess less activity with respect to neutrophil activation than LTB4 Lindgren et al., 1981 Lindgren et al., , 1982 Serhan et al., 1982; Ford-Hutchinson et al., 1983) . To determine whether neutroplasts also retain the ability to convert LTB4 into its terminal oxidation products, the initial fractions from the r.p. separation were pooled, evaporated to dryness, methyl-esterified and separated by s.p.-h.p.l.c. Both 20-hydroxy-and 20-carboxy-LTB4 were isolated from the neutroplast preparation in the same proportion as from the neutrophils (Table 1) .
Utilization of intrinsic arachidonate stores
The experiments above were all performed in the presence of added arachidonic acid. Having shown that neutroplasts can utilize free arachidonate to generate LTB4, we next examined whether neutroplasts were able to mobilize intrinsic arachidonic acid and to utilize it in forming lipoxygenase products. Neutroplasts exposed to A23187 (10 ltM) proved capable of forming LTB4, albeit in much smaller quantities than those generated in the presence of exogenously added arachidonate (30 pmol/mg of protein as against 300 pmol/mg of protein; Tables 1 and 2 ).
Neutrophil and neutroplast preparations are always contaminated by a small, but detectable, number of platelets, as demonstrated by the constant finding of 12-HETE among the lipoxygenase products. Previous work in this laboratory has shown that, after activation, platelets release free arachidonate, which can be used as a precursor by intact neutrophils for the generation of LTB4 (Marcus et al., 1982) . In order to determine whether the LTB4 found in the neutroplast preparations was generated from the intrinsic arachidonic acid of the neutroplast or from arachidonate released by the contaminating platelet population, we added large numbers of platelets to a neutroplast preparation, stimulated the mixture with the ionophore A23187, and isolated the lipoxygenase products. Neutroplasts did not utilize platelet arachidonate in significant quantities, as shown in* Table 2 . Neutroplasts generated the same amount of LTB4 with and without added platelets. The quantity of 12-HETE produced increased by more than 60-fold, showing that the platelets were active. In addition, the amount of (5S, 12S)-di-HETE (the double-lipoxygenation product) increased over 10-fold.
DISCUSSION
Many neutrophil functions have been linked to degranulation; these include aggregation, 02-generation and the mobilization of receptors for chemotactic factors (Ward & Becker, 1970; Mehta et al., 1981; Oseas et al., 1981; Fletcher et al., 1982) . Alternatively, Roos et al. Table 2 . Lipoxygenase products generated by neutroplasts and platelets (without exogenous arachidonic acid) Neutroplasts were incubated for 5 min at 37°C with 10 gZM-A23187 with or without platelets from 4 ml of platelet-rich plasma.
Reaction products were isolated as described in the Materials and methods section. (1983) and Korchak et al. (1983) , by means of neutroplast preparations, have shown that aggregation, release of toxic oxygen products, phagocytosis and changes in membrane potential in the neutrophil can proceed in the absence of degranulation. Preparations of cytosol from various cells and cell lines have been shown to generate various products of the lipoxygenase pathways. Interpretations of these experiments are fraught with difficulty, since different methods of preparing cytosol can lead to opposite conclusions (Shak & Goldstein, 1985; Soberman et al., 1985) , possibly owing to contamination with cell membranes or organelle fragments and contents. To examine whether granules and/or an intact mechanism of degranulation are required for leukotriene synthesis and catabolism, we utilized neutroplasts. We have found that neutroplasts synthesize 5-lipoxygenase products, including LTB4. Neutroplasts also contain the enzymes necessary to metabolize LTB4 to the more-polar, less-active products: 20-hydroxy-and 20-carboxy-LTB4.
We do not consider it appropriate to quantitatively compare neutroplast and neutrophil synthesis of these compounds. In addition to the donor-to-donor variation in the quantity of lipoxygenase products produced by neutrophils, there is also significant donor-related variation in the size and protein content of their neutroplasts; hence the variability of lipoxygenase products produced by neutroplasts is large. However, it is important to note thatt neutroplasts produce a significant amonunt of 5-lipoxygenase products in ratios similar to those generated by neutrophils.
Finallywehave-demonstrated not onlythat neutroplasts retain the ability to synthesize lipoxygenase products after the initial step of arachidonic acid liberation, but that these cell fragments can form the same products in the.absence of added arachidonate. Previous work has demonstrated that neutrophils can utilize arachidonic acid released from stimulated platelets to synthesize LTB4 (Marcus et al., 1982) . When suspensions were enriched in platelets (over 60-fold as measured by the increment in 1 2-HETE synthesis), no increase in the synthesis of LTB4 was found. Failure of neutroplasts to form LTB4 was not simply due to saturation of the lipoxygenase enzymes, since ionophore provoked a concomitant increase in the double-lipoxygenase product, (5S, 12S)-di-HETE. Moreover, adding free arachidonic acid (cf . Tables 1 and 2 ) resulted in enhanced synthesis of both LTB4 and (5S, 1 2S)-di-HETE.
Stimulated neutroplasts, in the presence of added arachidonate, generate larger quantities of 1 5-HETE than do neutrophils. In the absence ofadded arachidonate, the quantity of 15-HETE is almost undetectable. It is possible that, in contrast with added arachidonate, intrinsic arachidonic acid metabolized during stimulation may not be available to the 1 5-lipoxygenase enzyme. We have not, however, determined whether neutroplast 1 5-HETE is enzymically produced by examining the chirality of-the --OH grouping either by oxidative ozonolysis or application -to a chiral column. An alternative explanation is that the free arachidonate spontaneously reacts with active oxygen products produced by neutroplasts to form 15-HETE. Borgeat & Samuelsson (1979a) , in their initial observations on. neutrophil-derived 15-HETE, noted that the stereospecificity of this compound was less than would be expected if the 1 5-HETE was synthesized solely by means of an enzymic reaction and suggested that some 1 5-HETE may have been generated by non-specific oxidation. At present we cannot rule out either of these two possibilities.
We have demonstrated that neutroplasts can generate the more polar metabolites of LTB4, the 20-hydroxy-and 20-carboxy-leukotrienes. These products are less active than LTB4 in neutrophil aggregation, O2-and enzymerelease assays, and LTB4 may be inactivated in vivo by w-oxidation Lindgren et al., 1981 Lindgren et al., , 1982 Serhan et al., 1982; Ford-Hutchinson et al., 1983) . Chacos et al. (1982) and Oliw et al. (1982) have shown that liver microsomes can oxidize arachidonate, and it has been suggested by Shak & Goldstein (1984 that cytochrome P-450 is the site of the terminal oxidation of LTB4 and (5S,12S)-di-HETE. At present, we have no information as to whether neutroplasts contain what would constitute a 'microsomal fraction' isolated from neutrophils. Since neutroplasts do, however, form the w-oxidation products of leukotrienes, they contain the enzymes required for further metabolism of di-HETEs.
In summary, neutroplasts respond to the Ca2+ ionophore by mobilizing intrinsic arachidonate, activating the lipoxygenase pathway of arachidonate metabolism to synthesize mono-and di-HETE products, and metabolizing di-HETEs to their w-oxidation products. LTB4 synthesis and metabolism, therefore, proceeds unimpaired in the absence of organized intracellular structures.
